The PHF-1 (phospho-Ser396/Ser404) is a later-stage tauopathy marker, and a 24-hour LPS treatment may not strongly induce phosphorylation at these sites (Augustinack et al., 2002; Spires-Jones et al., 2009; Wesseling et al., 2020). Here, PHF1 is linked to tauopathy.